Influence of methimazole treatment on parameters of oxidative stress in patients with Graves' disease

Comparative Clinical Pathology

Volumn 15, Issue 1, 2006, Pages 49-54

  Gerenova, Julieta ^a,b   Gadjeva, Veselina ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b University Hospital   (Bulgaria)

Author keywords

Antioxidants; Graves' disease; Lipid peroxidation; Oxidative stress

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; LIPID; MALONALDEHYDE; SELENIUM; SUPEROXIDE DISMUTASE; THIAMAZOLE; THYROID HORMONE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HORMONAL REGULATION; HUMAN; HYPERTHYROIDISM; LIPID PEROXIDATION; LONG TERM CARE; MALE; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 33646896905     PISSN: 16185641     EISSN: 1618565X     Source Type: Journal    
DOI: 10.1007/s00580-006-0604-8     Document Type: Article

References (23)

1. Ademoglu E, Gokkusu C, Yarman S, Azizlerli H (1998) The effect of mrthimazole on oxidant and antioxidant system in patients with hyperthyroidism. Pharmacol Res 38:93-96
2. Asayama K, Dobashi K, Hayashibe H, Megata Y, Kato K (1987) Lipid peroxidation and free radical scavengers in thyroid function in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. Endocrinology 121:2112-2118
3. Beers R, Sizer T (1952) Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133-138
4. Bianchi G, Solaroli E, Zaccheroni V, Grossi G, Bargossi AM, Melchionda N, Marchesini G (1999) Oxidative stress and antioxidant metabolites in patients with hyperthyroidism: Effect of treatment. Horm Metab Res 31:620-624
5. Cadet J, Delatour T, Douki T, Gasparutto D, Pouget JP, Ravanat JL, Sauvaigo S (1999) Hydroxyl radicals and DNA base damage. Mutat Res 424:9-21
6. Howie AF, Arthur JR, Nicol F, Walker SW, Beech SG, Beckett GJ (1998) Identification of a 57-kilodalton selenoprotein in human thyrocytes as thioredoxin reductase and evidence that its expression is regulated through the calcium-phosphoinositol signaling. J Clin Endocrinol Metab 83:2052-2058
7. Kazakov VM, Katinas GS, Skorometz AA (1986) Pathogenesis of experimental thyrotoxic myopathy. Eur Neurol 25:212-224
8. Komosinska-Vassev K, Olczyk K, Kucharz EJ, Marcisz C, Winsz-Szczotka K, Kotulska A (2000) Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta 300:107-117
9. Mahoney JJ, Vreman HJ, Stevenson DK, Van Kessel AL (1993) Measurement of carboxyhemoglobin and total hemoglobin by five specialized spectrophotometers (CO-oximeters) in comparison with reference methods. Clin Chem 39:1693-1700
10. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-170
11. Pereira B, Costa Rosa LF, Safi DA, Bechara EJ, Curi R (1994) Control of superoxide dismutase, catalase and peroxide activities in rat lymphoid organs by thyroid hormones. J Endocrinol 140:73-77
12. Plaser ZA, Cushman LL, Jonson BC (1966) Estimation of product of lipid peroxidation (Malonyl Dialdehyde) in biochemical systems. Anal Biochem 16:359-364
13. Resch U, Helsel G, Tatzber F, Sinzinger H (2002) Antioxidant status in thyroid dysfunction. Clin Chem Lab Med 40:1132-1134
14. Rhee SG (1999) Redox signaling: Hydrogen peroxide as intracellular messenger. Exp Mol Med 31:53-59
15. Sadani GR, Nadkarni GD (1996) Role of tissue antioxidant defense in thyroid cancers. Cancer Lett 109:231-235
16. Seven R, Gelesgen R, Seven A, Erbil Y, Bozbora A, Burcak G (2001) Influence of propylthiouracil treatment on oxidative stress and nitric oxide in Basedow disease patients. J Toxicol Environ Health A 62:495-503
17. Sewerynek J, Wiktorska J, Nowak D, Lewinski A (2000) Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. Endocr Regul 34:83-89
18. Sugawara M, Kita T, Lee ED, Takamatsu J, Hagen JA, Kuma K, Medeiros-Neto GA (1988) Deficiency of thyroid superoxide dismutase in endemic goiter tissue. J Clin Endocrinol Metab 67:1156-1161
19. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497-500
20. Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, Hatfield DL, Gladyshev VN (1999) Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem 274:24522-24530
21. Venditti P, Balestrieri M, Di Meo S, De Leo T (1997) Effect of thyroid state on lipid peroxidation, antioxidant defences and susceptibility to oxidative stress in rat tissues. J Endocrinol 155:151-157
22. Vrca VB, Skreb F, Cepelak I, Romic Z, Mayer L (2004) Supplementation with antioxidants in the treatment of Graves' disease: The effect on glutathione peroxidase activity and concentration of selenium. Clin Chim Acta 341:55-63
23. Wilson R, Chopra M, Bradley H, Mckillop JH, Smith WE, Thomson JA (1989) Free radicals and Graves' disease: The effect of therapy. Clin Endocrinol 30:429-433